BioTechX 2025 is Europe’s flagship event for decision makers and thought leaders working in omics, diagnostics and R&D from across Europe and beyond. This year’s event will be bigger than ever with 3500+ senior decision makers in attendance.
From multiomic data management to the development of personalised therapies and data generation this event brings together the advancements in AI and Drug development, quantum pharm, precision medicine, big data and much more.
Cambridge Consultants will be at Capgemini booth #513 during the event to meet with clients and discuss new advancements in biotech. Please stop by if you are attending the show.
Joe brings products to market for drug delivery, diagnostics and minimally invasive surgery, having led the R&D of high risk (class 3) devices, including the regulatory approach and development of mechanical, electronic and software solutions, utilising the latest developments in Statistical Machine Learning, data science and Artificial Intelligence.
Ben has focused on science and engineering of medical devices and diagnostics for over 25 years. He has worked across patient monitoring, surgical navigation, in-vitro diagnostics and drug delivery.
Helping our clients develop breakthrough medical devices. Simon helps to bring unparalleled technology, clinical insight and medical device development experience to developing advanced emerging medical technologies and therapies such as Synthetic Biology, Artificial Intelligence, Digital Health, Smart Implants and Cell & Gene Therapies.